Delivery Order SPE2DB25D3202-SPE2DB25FTADJ

Award Date 4/18/25
Potential Completion Date 4/21/25
Potential Value $5.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,947.18, is for the delivery of 4,567,955,867 units of the medication teriparatide 620 mcg/2.48 ml. The contract has an ultimate completion date of April 18, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00, which provides a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,943,582 units of the medication teriparatide 560mcg/2.24ml pen, with a ceiling value of $11,646.66 and a performance period through April 17, 2025. The contract is not set aside and was awarded on April 16, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,278.41 contract is for the supply of 4567875629 TERIPARATIDE 560MCG/2.24ML PEN 2.24ML, a prescription medication. The contract has an ultimate completion date of April 11, 2025 and does not utilize a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,446.15 award is for the supply of 4,567,999,513 units of the medication Teriparatide 560mcg/2.24ml pen with a 2.24ml volume. The contract has an ultimate completion date of April 23, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,330.16, is for the delivery of TERIPARATIDE 600 MCG/2.4ML PEN 2.4ML, a medication used in the treatment of osteoporosis. The contract has a completion date of January 9, 2025 and is a Firm Fixed Price (FFP) contract. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Teriparatide 600 mcg/2.4 mL pens. The contract has a ceiling value of $2,100.62 and a period of performance through September 5, 2024. It is a firm fixed-price contract, with no set-aside designation. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) vehicle between AmerisourceBergen and the DLA Troop...
This federal contract award, valued at $5,108.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4,568,078,779 units of the medication Teriparatide 560MCG/2.24ML Pen 2.24ML. The contract has an ultimate completion date of April 30, 2025 and is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical distribution company. The contract is for the delivery of Teriparatide 620 mcg/2.48 ml medication, with a total ceiling value of $2,598.99 and a period of performance through April 9, 2024. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) awarded to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,198,697 units of the drug Teriparatide 600 mcg/2.4 ml pen. The contract has a ceiling value of $4,419.64 and a completion date of October 25, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract was not set aside for any specific business type. AmerisourceBergen holds a significant...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corporation, a wholly owned subsidiary of Amerisourcebergen Corporation, to provide 4,563,927,592 units of the pharmaceutical product Teriparatide 600 mcg/2.4ml pen at a ceiling value of $2,299.97. The award, which has an ultimate completion date of March 12, 2024, is part of a larger indefinite delivery contract (IDC) valued up to...
  • SPE2DB25D3202
    Indefinite Delivery Contract
  • SPE2DB25D3202-SPE2DB25FTADJ
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,289.24, is for the delivery of 4,567,969,223 units of the medication Teriparatide 560MCG/2.24ML Pen 2.24ML. The contract has an ultimate completion date of April 21, 2025 and was awarded on April 18, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. The contract is not designated as a set-aside.

Generated 7/18/25, 10:06 AM